MDT

SEC source: 0001127602-19-021496 · form4a.xml · nonDerivative · entry 1

Powell Kendall J · CIK 0001298823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,784

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 524 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021493 · form4a.xml · nonDerivative · entry 1

Lenehan James T · CIK 0001189009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,951

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 141 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021487 · form4a.xml · nonDerivative · entry 1

DONNELLY SCOTT C · CIK 0001233158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,359

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 98 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021484 · form4a.xml · nonDerivative · entry 1

ARNOLD CRAIG · CIK 0001188578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,053

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 50 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021489 · form4a.xml · nonDerivative · entry 1

HOGAN RANDALL J · CIK 0001189049 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,579

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 50 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021481 · form4a.xml · nonDerivative · entry 1

ANDERSON RICHARD H · CIK 0001200334 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,441

F1 · kind: This restricted stock unit award will vest on the one-year anniversary of the grant date.

F2 · balance_after: This balance increased by 519 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021492 · form4a.xml · nonDerivative · entry 1

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,311

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 219 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021495 · form4a.xml · nonDerivative · entry 1

NABEL ELIZABETH G · CIK 0001619929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,452

F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date.

F2 · balance_after: This balance increased by 50 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-014200 · form4.xml · derivative · entry 2

OLEARY DENISE M · CIK 0001145159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,671 shares

Expires 2019-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-014200 · form4.xml · nonDerivative · entry 1

OLEARY DENISE M · CIK 0001145159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This balance increased by 547 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-013603 · form4.xml · nonDerivative · entry 1

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,241

F1 · security: This balance increased by 616 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-021490 · form4a.xml · nonDerivative · entry 1

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,241

F1 · security: This balance increased by 616 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-010036 · form4.xml · derivative · entry 2

Lenehan James T · CIK 0001189009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,671 shares

Expires 2019-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-19-010036 · form4.xml · nonDerivative · entry 1

Lenehan James T · CIK 0001189009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This balance increased by 403 shares due to exempt transactions such as dividend reinvestment

SEC source: 0001127602-19-001695 · form4.xml · nonDerivative · entry 1

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 570,722

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.5 to $84.77, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4.

F2 · balance_after: This balance increased by 2,326 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-19-001696 · form4.xml · nonDerivative · entry 1

PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,680

F1 · balance_after: This balance increased by 309 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-18-034991 · form4.xml · nonDerivative · entry 1

WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,590

F1 · balance_after: This balance increased by 214 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-18-031436 · form4.xml · derivative · entry 2

Liddicoat John R · CIK 0001752060 · EVP & President of Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,157

Underlying: Ordinary Shares · 17,157 shares

Expires 2028-10-29

F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning from July 30, 2018.

SEC source: 0001127602-18-031436 · form4.xml · nonDerivative · entry 1

Liddicoat John R · CIK 0001752060 · EVP & President of Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,043

F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2 · balance_after: This balance increased by 293 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-18-028314 · form4.xml · derivative · entry 5

Martha Geoffrey · CIK 0001560409 · EVP & GroupPres Restora Therap

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 21,129 shares

Expires 2022-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option to purchase 21,129 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-028314 · form4.xml · derivative · entry 4

Martha Geoffrey · CIK 0001560409 · EVP & GroupPres Restora Therap

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 28,670 shares

Expires 2021-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 28,670 ordinary shares of New Medtronic for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 28,670 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-028314 · form4.xml · nonDerivative · entry 3

Martha Geoffrey · CIK 0001560409 · EVP & GroupPres Restora Therap

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,202

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.911 to $97.965, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001127602-18-028314 · form4.xml · nonDerivative · entry 2

Martha Geoffrey · CIK 0001560409 · EVP & GroupPres Restora Therap

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-028314 · form4.xml · nonDerivative · entry 1

Martha Geoffrey · CIK 0001560409 · EVP & GroupPres Restora Therap

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-027799 · form4.xml · nonDerivative · entry 2

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · 2018 GRAT

Disclosed balance after: 10,000

SEC source: 0001127602-18-027799 · form4.xml · nonDerivative · entry 1

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,396

SEC source: 0001127602-18-027247 · form4.xml · nonDerivative · entry 2

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 566,396

SEC source: 0001127602-18-027247 · form4.xml · nonDerivative · entry 1

ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · GRAT

Disclosed balance after: 7,615

SEC source: 0001127602-18-026803 · form4.xml · derivative · entry 7

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 18,324 shares

Expires 2024-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.

SEC source: 0001127602-18-026803 · form4.xml · derivative · entry 6

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 7,436 shares

Expires 2024-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.

SEC source: 0001127602-18-026803 · form4.xml · derivative · entry 5

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 399 shares

Expires 2024-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.

SEC source: 0001127602-18-026803 · form4.xml · nonDerivative · entry 4

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,647

F1 · kind: The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.04 to $96.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001127602-18-026803 · form4.xml · nonDerivative · entry 3

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-18-026803 · form4.xml · nonDerivative · entry 2

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-18-026803 · form4.xml · nonDerivative · entry 1

HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001127602-18-026464 · form4.xml · derivative · entry 3

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 41,227 shares

Expires 2022-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 41,227 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,227 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026464 · form4.xml · nonDerivative · entry 2

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,403

F1 · price: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $95.82 to $95.9850, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.

SEC source: 0001127602-18-026464 · form4.xml · nonDerivative · entry 1

Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-026109 · form4.xml · nonDerivative · entry 1

ANDERSON RICHARD H · CIK 0001200334 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,920

F1 · balance_after: This balance increased by 171 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-18-026214 · form4.xml · derivative · entry 5

POZEN ROBERT C · CIK 0001278408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,813 shares

Expires 2020-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026214 · form4.xml · derivative · entry 4

POZEN ROBERT C · CIK 0001278408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,671 shares

Expires 2019-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 3

POZEN ROBERT C · CIK 0001278408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,964

SEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 2

POZEN ROBERT C · CIK 0001278408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-026214 · form4.xml · nonDerivative · entry 1

POZEN ROBERT C · CIK 0001278408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This balance increased 155 shares due to exempt transactions such as dividend reinvestment.

SEC source: 0001127602-18-026096 · form4.xml · derivative · entry 9

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 84,060 shares

Expires 2021-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026096 · form4.xml · derivative · entry 8

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 70,984 shares

Expires 2020-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026096 · form4.xml · derivative · entry 7

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 23,175 shares

Expires 2020-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

SEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 4

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,180

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

SEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 3

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 2

COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.